Inflammation: the link between comorbidities, genetics, and Alzheimer's disease

EA Newcombe, J Camats-Perna, ML Silva… - Journal of …, 2018 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder, most cases of which lack a clear
causative event. This has made the disease difficult to characterize and, thus, diagnose …

Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond

C Weber, AJR Habenicht… - European heart …, 2023 - academic.oup.com
This review based on the ESC William Harvey Lecture in Basic Science 2022 highlights
recent experimental and translational progress on the therapeutic targeting of the …

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications

MA Martin-Serrano, B Kepecs, M Torres-Martin… - Gut, 2023 - gut.bmj.com
Objective The diversity of the tumour microenvironment (TME) of intrahepatic
cholangiocarcinoma (iCCA) has not been comprehensively assessed. We aimed to …

Chemokines from a structural perspective

MC Miller, KH Mayo - International journal of molecular sciences, 2017 - mdpi.com
Chemokines are a family of small, highly conserved cytokines that mediate various
biological processes, including chemotaxis, hematopoiesis, and angiogenesis, and that …

Surface modified cellulose nanomaterials: a source of non-spherical nanoparticles for drug delivery

YY Khine, MH Stenzel - Materials Horizons, 2020 - pubs.rsc.org
Cellulose nanomaterials, often called nanocellulose, have created a lot of buzz as a
renewable building block for new materials such as nanocomposites, aerogels and …

Regulation of immune response by bioactive ions released from silicate bioceramics for bone regeneration

Y Huang, C Wu, X Zhang, J Chang, K Dai - Acta biomaterialia, 2018 - Elsevier
Silicate bioceramics have been considered to possess a wide prospect of clinical
application for orthopedic tissue regeneration due to their excellent osteogenesis and …

Insulin-degrading enzyme in the fight against Alzheimer's disease

IV Kurochkin, E Guarnera, IN Berezovsky - Trends in pharmacological …, 2018 - cell.com
After decades of research and clinical trials there is still no cure for Alzheimer's disease
(AD). While impaired clearance of amyloid beta (Aβ) peptides is considered as one of the …

CCL4 signaling in the tumor microenvironment

N Mukaida, S Sasaki, T Baba - … : the role of chemokines–part A, 2020 - Springer
CCL4, a CC chemokine, previously known as macrophage inflammatory protein (MIP)-1β,
has diverse effects on various types of immune and nonimmune cells by the virtue of its …

Targeting chemokine—glycosaminoglycan interactions to inhibit inflammation

H Crijns, V Vanheule, P Proost - Frontiers in immunology, 2020 - frontiersin.org
Leukocyte migration into tissues depends on the activity of chemokines that form
concentration gradients to guide leukocytes to a specific site. Interaction of chemokines with …

Chemokine interactome map** enables tailored intervention in acute and chronic inflammation

P Von Hundelshausen, SM Agten, V Eckardt… - Science translational …, 2017 - science.org
Chemokines orchestrate leukocyte trafficking and function in health and disease.
Heterophilic interactions between chemokines in a given microenvironment may amplify …